Imagine catching Covid not once, not twice, but six times, and walking away with more than just antibodies: weight gain, fatigue, stubborn skin issues. For Darren Crowder, this wasn’t just a health crisis; it was the inflexion point. Battling melanin‑rich skin challenges and discovering how fragmented and exclusive dermatology really is, Darren decided that enough was enough. In September 2024, he ditched a three‑decade safe corporate software executive career to launch Enbodie, an AI‑driven preventative whole health care platform on a mission: to democratise dermatology and toxicology for everyone, especially marginalised communities.
The Problem
Dermatology by Luck, not Design
In parts of Africa and India, there’s one dermatologist per million people. In the UK? Only one per 50,400, and many still wait months to see that specialist. That means countless people, especially those with melanin‑rich skin or gender-diverse identities, go untreated or misdiagnosed.
Ingredient Labyrinths and Greenwash Galore
Ingredient labels are dusty and opaque, greenwashing is rampant, and consumers are left guessing. Add endocrine disruptors, hidden toxins, and value misalignment, and you have a triple threat. About 1.8 billion people worldwide suffer from untreated skin conditions, eczema, rosacea, acne, psoriasis, even melanoma and that figure skews disproportionately toward underserved demographics, whilst also being not very inclusive.
Hidden Costs of Inaction
Skincare mishaps cost consumers time, money, confidence, and even risk legal headlines for brands. Retailers lose up to 17% of sales due to poor product fits; PFAS-related lawsuits have topped billions. Consumers face medical bills, brands face reputational loss, and the planet suffers from mounting plastic waste and unsustainable supply chains.
Enbodie’s Solution
Smart Phone = Smart Skin Ally
Enbodie turns your everyday smartphone into a personal care intelligence companion. Using selfie analysis, daily routines and barcode scans, the app assesses skin condition, ingredient safety, ESG metrics and personal values all in real time. That means people everywhere can access preventive, personalised guidance, no specialist needed.
A Sophisticated Product & Ingredients Taxonomy Millions Strong
At the core lies our comprehensive database and dynamic knowledge graph combining 111 million products and ingredients with 45 million ocular, genomic and cosmetic toxicology data points. This powerful foundation features a detailed taxonomy of integrated toxicology data, sustainability scoring and compliance information. It analyses and flags endocrine disruptors, allergens, banned chemicals, unsustainable packaging, and redundant actives tailored to skin type, budget and values. It’s ethics meets science at scale.
Ethnicity‑Aware AI and Clinical Precision
The platform’s AI is trained on millions of anonymised, ethnically diverse user images. It’s clinically validated, respects UK/EU margin‑of‑safety standards, GDPR, SOC 2, HIPAA and HL7 compliance and even anchors anonymised data on blockchain to power its Data-as-a-Service (DaaS) Platform for Enterprises such as CPG, Retailers and Legal Services Industries.
Results That Speak
In a preview trial launched in January 2025, several hundred users (ethnically and gender diverse) engaged with Enbodie’s platform. Outcomes included:
● An average of 3.4 product changes per user, switching to safer alternatives.
● Around £60 saving per month per participant.
● ESG footprint improvement exceeding 80% per user.
● Consumers decreased exposure to harmful ingredients by up to 50% and reduced ingredient clutter by 15–20%.
Key Features & What Sets Embodie Apart
- RoutineReveal: A free feature where users input their daily products and receive a detailed insights report within 24 hours, including allergens and transparency checks, with safer alternatives highlighted.
- Browser Extension: Works on shopping platforms like Amazon, Sephora, Temu, revealing hidden toxins, pricing gaps, animal‑derived ingredients, and ESG information instantly at product pages on the web.
- Ethnicity & Gender‑Aware Guidance: Not a plug‑and‑play one‑size‑fits‑all. Recommendations respect cultural/ethical values, vegan, halal, kosher, Jain, and biological differences in melanin‑rich or gender‑affirming skin care journeys.
- Business API (Enbodie Enterprise DaaS): Brands and insurers can license the platform’s data API to power compliance tooling, reformulation insight, product recommendations, and consumer behaviour analytics, enabling ethical innovation and traceability across industries.
- Data Flywheel & Privacy‑First Architecture: Each scan enriches the database, improving future recommendations. Data is anonymised, stored via blockchain, and shared only with explicit user consent, building trust with consumers and enterprise partners alike.
Milestones & Credibility
- Founding: Darren Crowder launched Enbodie in London in September 2024, transitioning from a thirty‑year high‑performing tech career to health‑tech innovation.
- Team: Four doctors, two PhD scientists (each with patents), and 180+ man‑years of coding, SaaS and revenue experience.
- Revenue: Pre‑MVP traction with revenue from early customers. Several hundred user AI trial released via word of mouth.
- Recognition: Recognised as a MedTech38 Winner across the UK/EU in August 2025 as well as named one of the UK/EU’s Top 60 Sustainability Startups by TechRound in July 2025.
- Partnerships: Collaborations with Microsoft for Startups, NVIDIA Inception, British Beauty Council, Innovate UK, Virgin Startups and more. On Innovate UK’s business accelerator.
- Regulatory & IP: IP audit grant passed with UK Intellectual Property Office at 84% with Innovate UK and IP21 (with 16 patents). EIS/SEIS advance assurance in place, investor‑ready credentials ticked.
- Compliance & Infrastructure: Built on Microsoft Azure, GDPR/SOC 2/HIPAA/HL7 compliant, blockchain‑backed storage and privacy‑first design for scaling globally.
Vision for the Future
Enbodie isn’t stopping at skincare. Darren and team are currently building CARE: a context‑aware, conversational AI Triage “first line” framework integrating GPs, dermatologists, toxicologists, neuroscientists, nutritionists, and many other health experts. The ambition: a holistic preventative health platform across routine, wellness and systemic care, reducing healthcare costs and improving outcomes before symptoms escalate.
During 2026, Enbodie plans to support over one million users across the globe, driving measurable change in product safety, ESG outcomes, ethical product development, and clinical-grade personal care. Major expansion targets include embedding with health insurers and systems like the NHS, and enabling enterprise brands to adopt safer innovation informed byconsumers, powered by Enbodie’s Enterprise DaaS and its massive, continuously enriched data network.
What Makes Enbodie Investor-Ready?
● Exceptional team: Clinicians, scientists and engineers with proven track records and deep industry expertise.
● Revenue before MVP: Early monetisation and strong trial engagement show market validation.
● IP and tax incentives in place: IP audit grant, UK patent pipeline, EIS/SEIS assurances. Estimates suggest a valuation uplift of 15–40%.
● Strategic brand partnerships: Microsoft, NVIDIA, British Beauty Council and more. Access to funding, infrastructure and co‑innovation opportunities.
● Global impact potential: Scalable model addressing health safety, dermatology deserts, inequality in care access, and ESG reform across beauty and wellness channels.
● Compliance, Regulations and data security: Built to rigorous standards – SaMD, AIaMD, GDPR, SOC 2, HIPAA, HL7, blockchain layering ensure trust and scale. Sitting at the epicenter of multiple industries forced into emergency reformulation by 2027 PFAS bans, every major brand desperately needs real-time ingredient intelligence to avoid regulatory lockout across their most profitable markets.
Enbodie is more than an app or even a startup. It’s a movement to harmonise personal care with planetary care, one scan at a time. It rewrites the health and beauty narrative for those too often underserved by mainstream care. It empowers consumers, elevates brands, and rewires industry norms all with science, transparency and inclusivity at its core.
As Darren says:
“What if your bathroom cabinet could transparently speak? With Enbodie.me, we’re giving it that voice, peeling back assumptions and revealing truths that guide smarter decisions for both people and planet.”
Enbodie may be young, but from pandemic-born frustration to million‑user ambition within two years, it’s shaping up to be the conscious care revolution we didn’t know we needed. Investors, you’re looking at where personal care meets prevention, powered by ethics, data and inclusion.
Feel free to reach out to Darren Crowder
Founder and CEO at Enbodie
darren.crowder@enbodie.me